Key result
Mechanical prostheses linked to ~80% fewer re-operations vs. bioprostheses in children under 12.
Why the study?
Valve replacement outcomes in children under 12 years old, including differences between biological and mechanical prostheses, required evaluation.
Do mechanical prostheses reduce re-operations and mortality compared to biological prostheses in children under 12 years old undergoing valve replacement?
Cohort (n=44)
No
Do mechanical prostheses reduce re-operations and mortality compared to biological prostheses in children under 12 years old undergoing valve replacement?
In children under 12 years old, mechanical prostheses are associated with significantly fewer re-operations and lower rates of infectious endocarditis compared to biological prostheses.
Answers are grounded in this paper and cite their sources.
May support mechanical prostheses to reduce reoperations in young children; leaves open randomized confirmation and mortality effects.
OBJECTIVE: The aim of this work was the follow-up and evaluation of valve replacement in children under 12 years of age. METHODS: Forty-four children less than 12 years old were underwent valve replacement at INCOR-HCFMUSP between January 1986 and December 1992. Forty (91%) were rheumatic, 39 (88.7%) were in functional classes II or IV, 19 (43.2%) were operated upon on an emergency basis, and 6 (13.6%) had atrial fibrillation. Biological prostheses (BP) were employed in 26 patients (59.1%), and mechanical prostheses (MP) in 18 (40.9%). Mitral valves were replaced in 30 (68.7%), aortic valves in 8 (18.2%), a tricuspid valve in 1 (2.3%), and double (aortic and mitral) valves in 5 (11.4) of the patients. RESULTS: Hospital mortality was of 4.5% (2 cases). The mean follow-up period was 5.8 years. Re-operations occurred in 63.3% of the patients with BP and in 12.5% of those with MP (p=0.002). Infectious endocarditis was present in 26.3% of the BP, but in none of the cases of MP (p=0.049). Thrombosis occurred in 2 (12.5%) and hemorrhage in one (6.5%) of the patients with a MP. Delayed mortality occurred in 5 (11.9%) of the patients over a mean period of 2.6 years; four had had BP and one had a MP (NS). Actuarial survival and re-operation-free curves after 10 years were respectively, 82.5+/-7.7 (SD)% and 20.6+/-15.9%. CONCLUSION: Patients with MP required fewer re-operation, had less infectious endocarditis and lower late mortality rates compared with patients with bioprostheses. The former, therefore, appear to be the best valve replacement for pediatric patients.
No takes yet. Share an insight, caveat, or question.
Atik et al. (1999) conducted a cohort in Valve disease requiring replacement (n=44). Mechanical prostheses vs. Biological prostheses was evaluated on Re-operation (p=0.002). Mechanical prostheses were associated with fewer re-operations and less infectious endocarditis compared to biological prostheses in children under 12.
Synapse has enriched 10 related papers. Consider them for comparative context: